- Home
- SST vs CRIS Comparison
SST vs CRIS Comparison
Compare SST & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SST
- CRIS
- Stock Information
- Founded
- SST 2013
- CRIS 2000
- Country
- SST United States
- CRIS United States
- Employees
- SST N/A
- CRIS N/A
- Industry
- SST Diversified Commercial Services
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SST Consumer Discretionary
- CRIS Health Care
- Exchange
- SST Nasdaq
- CRIS Nasdaq
- Market Cap
- SST 23.3M
- CRIS 21.3M
- IPO Year
- SST N/A
- CRIS 2000
- Fundamental
- Price
- SST $6.24
- CRIS $1.81
- Analyst Decision
- SST Strong Buy
- CRIS Strong Buy
- Analyst Count
- SST 1
- CRIS 2
- Target Price
- SST $500.00
- CRIS $16.50
- AVG Volume (30 Days)
- SST 365.1K
- CRIS 163.8K
- Earning Date
- SST 08-07-2025
- CRIS 07-31-2025
- Dividend Yield
- SST N/A
- CRIS N/A
- EPS Growth
- SST N/A
- CRIS N/A
- EPS
- SST N/A
- CRIS N/A
- Revenue
- SST $333,521,000.00
- CRIS $11,202,000.00
- Revenue This Year
- SST N/A
- CRIS N/A
- Revenue Next Year
- SST $8.39
- CRIS $10.67
- P/E Ratio
- SST N/A
- CRIS N/A
- Revenue Growth
- SST N/A
- CRIS 14.17
- 52 Week Low
- SST $2.90
- CRIS $1.02
- 52 Week High
- SST $15.70
- CRIS $8.29
- Technical
- Relative Strength Index (RSI)
- SST 53.33
- CRIS 43.58
- Support Level
- SST $5.20
- CRIS $1.50
- Resistance Level
- SST $6.82
- CRIS $1.98
- Average True Range (ATR)
- SST 2.03
- CRIS 0.19
- MACD
- SST -0.18
- CRIS -0.05
- Stochastic Oscillator
- SST 14.14
- CRIS 43.88
About SST System1 Inc.
System1 Inc develops technology and data science to operate a responsive acquisition marketing platform. It serves customers in the areas of health and wellness, automotive, finance, travel, and entertainment. The company's segment includes Owned and Operated Advertising (O&O); and Partner Network. It generates maximum revenue from the Owned and Operated Advertising (O&O) segment. Geographically, it operates in United States and Other countries.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.